Next Article in Journal
Progress Report: Antimicrobial Drug Discovery in the Resistance Era
Next Article in Special Issue
Effectiveness and Cost-Effectiveness Profile of Second-Line Treatments with Nivolumab, Pembrolizumab and Atezolizumab in Patients with Advanced Non-Small Cell Lung Cancer
Previous Article in Journal
Mapping the Lipids of Skin Sebaceous Glands and Hair Follicles by High Spatial Resolution MALDI Imaging Mass Spectrometry
Previous Article in Special Issue
Metformin Enhances TKI-Afatinib Cytotoxic Effect, Causing Downregulation of Glycolysis, Epithelial–Mesenchymal Transition, and EGFR-Signaling Pathway Activation in Lung Cancer Cells
 
 
Article

Article Versions Notes

Pharmaceuticals 2022, 15(4), 412; https://doi.org/10.3390/ph15040412
Action Date Notes Link
article pdf uploaded. 28 March 2022 13:34 CEST Version of Record https://www.mdpi.com/1424-8247/15/4/412/pdf-vor
article xml file uploaded 29 March 2022 10:51 CEST Original file -
article xml uploaded. 29 March 2022 10:51 CEST Update https://www.mdpi.com/1424-8247/15/4/412/xml
article pdf uploaded. 29 March 2022 10:51 CEST Updated version of record https://www.mdpi.com/1424-8247/15/4/412/pdf
article html file updated 29 March 2022 10:53 CEST Original file -
article html file updated 2 August 2022 16:03 CEST Update https://www.mdpi.com/1424-8247/15/4/412/html
Back to TopTop